Mutation of phosphoserine 389 affects p53 function in vivo (Q42807102)

7 November 2017

title

Mutation of phosphoserine 389 affects p53 function in vivo (English)

1 reference

7 November 2017

Hao M

1

1 reference

7 November 2017

Lowy AM

2

1 reference

7 November 2017

Kapoor M

3

1 reference

7 November 2017

Deffie A

4

1 reference

7 November 2017

Liu G

5

1 reference

7 November 2017

Lozano G

6

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

Journal of Biological Chemistry

7 November 2017

published in

1 reference

7 November 2017

volume

271

1 reference

7 November 2017

issue

46

1 reference

7 November 2017

page(s)

29380-29385

1 reference

7 November 2017

cites work

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

The p53-mdm-2 autoregulatory feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Phosphorylation sites in the amino-terminal region of mouse p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Phosphorylation of p53 in normal and simian virus 40-transformed NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Regulation of the specific DNA binding function of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Cyclin E restores p53 activity in contact-inhibited cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Site-directed mutagenesis of virtually any plasmid by eliminating a unique site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

High-efficiency transformation of mammalian cells by plasmid DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

The regulation of transcription by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

The Tumor Suppressor p53 Regulates Its Own Transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Analysis of p53 mutants for transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Rearrangement of the p53 gene in human osteogenic sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Cyclin-dependent regulation of G1 in mammalian fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

Small peptides activate the latent sequence-specific DNA binding function of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.46.29380

21 January 2018

Identifiers

DOI

10.1074/JBC.271.46.29380

1 reference

7 November 2017

1 reference